Gelesis Holdings Inc
Change company Symbol lookup
Select an option...
GLS Gelesis Holdings Inc
NVAX Novavax Inc
EBIX Ebix Inc
FCRD First Eagle Alternative Capital BDC Inc
RWAY Runway Growth Finance Corp
LITB LightInTheBox Holding Co Ltd
UEC Uranium Energy Corp
NEE Nextera Energy Inc
MANT ManTech International Corp
AMPE Ampio Pharmaceuticals Inc
Go

Company profile

Gelesis Holdings, Inc., formerly Capstar Special Purpose Acquisition Corp., is a commercial stage biotherapeutics company built for consumer engagement. It focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate include GS200, provides additional potential health benefits in prediabetics and type two diabetics. It is also developing GS300, treatment for NAFLD and NASH and GS500, for the treatment of FC.

Closing Price
$6.53
Day's Change
-0.83 (-11.28%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.24
Day's Low
6.00
Volume
(Light)
Volume:
237,378

10-day average volume:
492,093
237,378
  • Prev Close
    7.36
  • Today's Open
    7.33
  • Day's Range
    6.00-8.24
  • Avg Vol (10-day)
    492.1K
  • Last (time)
    7:00p ET 01/14/22
  • Last (size)
    19
  • 52-Wk Range
    6.00 - 12.23
    LowHigh
  • (01/10/22 - 01/14/22)
    8.76%
  • 38.0%
  • Market Cap
    --
  • Shares Outstanding
    --
  • -0.55
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • (% of float 12/31/21)
    0.98

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.